Stocks to Watch: Intel, Deckers, Edwards Lifesciences, GenmabMorningStar·3 hours agoEW-0.65%GMAB+1.11%
EW: Q2 sales up 12.5% year-over-year; guidance raised on strong TAVR and TMTT growthQuartr·3 hours agoEW-0.65%
Edwards Lifesciences (NYSE:EW) Issues Earnings Results, Beats Expectations By $0.04 EPSMarket Beat·6 hours agoEW-0.65%
Heart-Valve Maker Edwards Lifesciences Launches On Beat-And-Raise Second QuarterUnusual Whales·6 hours agoEW-0.65%
Edwards Lifesciences | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.741 BEarnings Watch·6 hours agoEW-0.65%
EW: Q2 sales up 13.6% to $1.74B; guidance raised on strong TAVR/TMTT growth and robust cash positionQuartr·6 hours agoEW-0.65%
Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.benzinga_article·6 hours agoEW-0.65%
